Previous 10 | Next 10 |
Thorne HealthTech Reports Fourth Quarter and Full-Year 2022 Results PR Newswire Net Sales Growth of 24.1% and Adj. EBITDA 1 growth of 19.1% for Full-Year 2022; Provides Full-Year 2023 Guidance NEW YORK , March 30, 2023 /PRNewswire/ -- Thorne HealthTec...
Thorne HealthTech Announces Fourth Quarter and Full-Year 2022 Earnings Release Date and Conference Call PR Newswire NEW YORK , March 29, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personaliz...
2023-03-13 07:43:52 ET Science-driven wellness company, Thorne HealthTech ( NASDAQ: THRN ) has appointed Saloni Varma as CFO. Varma was also former CFO of ByHeart and has held various leadership roles at purpose-driven brands like Chobani, Dove, and Talenti, focusing ...
Thorne HealthTech Appoints Saloni Varma as New Chief Financial Officer PR Newswire NEW YORK , March 13, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne" or "Thorne HealthTech") (NASDAQ: THRN), a leader in developing innovative solutions for a personalized a...
Thorne HealthTech Named to Fast Company's Annual List of the World's Most Innovative Companies for 2023 PR Newswire NEW YORK , March 2, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne" or "Thorne HealthTech") (NASDAQ: THRN), a leader in developing innovativ...
Thorne HealthTech ( NASDAQ: THRN ) has acquired all of the outstanding stock of PreCon Health for an aggregate purchase price of $5M. PreCon is focused on scientific discovery, innovation, and advancing safe and effective products that support healthy brain function. The acquisiti...
THORNE HEALTHTECH ACQUIRES PRECON HEALTH PR Newswire Acquisition of PreCon strengthens brain health portfolio and provides access to world-class scientific advisory board NEW YORK , Feb. 3, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne" or "Thorne...
Summary Thorne HealthTech continues to face lower revenue growth due to macro uncertainty. Management prefers to temporarily sacrifice the gross margin, but increase brand awareness. The company's shares retain fundamental growth potential. Introduction Thorne HealthTe...
THORNE HEALTHTECH'S ONEDRAW DEVICE USED IN DEPARTMENT OF DEFENSE'S CANCER MOONSHOT 2.0 PROJECT, PROMETHEUS, AS PART OF PRESIDENT BIDEN INITIATIVE PR Newswire NEW YORK , Nov. 17, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech" or "Thorne"...
Thorne HealthTech to Participate in Evercore ISI HEALTHCONx Conference PR Newswire NEW YORK , Nov. 16, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech" or "the Company") (NASDAQ: THRN), a leader in developing personalized, innovative solu...
News, Short Squeeze, Breakout and More Instantly...
Thorne Healthtech Inc. Company Name:
THRN Stock Symbol:
NASDAQ Market:
Thorne Healthtech Inc. Website:
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Thorne Healthtech Inc. (THRN) is expected to report for Q3 2023
L Catterton Completes Acquisition of Thorne HealthTech, Inc. PR Newswire NEW YORK , Oct. 16, 2023 /PRNewswire/ -- L Catterton, a leading global consumer-focused investment firm, today announced the successful completion of its acquisition of Thorne ...